CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Open account
☰
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Open account
✖

US open Futures mixed as stimulus approved yields rise

Article By: ,  Senior Market Analyst
March 12, 2021 8:45 AM

US futures

Dow  futures +0.2% at 32557

S&P futures -0.2% at 3927

Nasdaq futures -1.2% at 12890

In Europe

FTSE +0.1% at 6742

Dax -0.65% at 14480

Euro Stoxx -0.4% at 3828

Learn more about trading indices


Biden signs off on $1.9 trillion stimulus & vaccine drive

President Biden signed off on the largest fiscal stimulus bill in US history at the same time as pledging an acceleration to the vaccine drive.

Biden promised that all Americans would have the covid vaccine by 1 May to enable to return to normal life by 4 July Independence Day.

Combined, the stimulus and the vaccination pledge are driving economic recovery expectations and inflation expectations higher once again.

US 10 year yields which had dropped below 1.5% on Wednesday are now back over 1.60% taking the shine off stocks which boosting the US Dollar.


Stocks point to a mixed open

US stocks are pointing to a mixed start. The more cyclical Dow Jones is looking to extend gains into the weekend as the drive for value intensifies. The tech heavy Nasdaq is bracing itself for a deep selloff. Rising treasury yields are once again raising questions over lofty growth stock valuation. Meanwhile the tech sector in the S&P is dragging on the index.

Stocks in focus :

Tesla -2.9% pre-market after a fire at the electric car makers factory in California. The were no injuries and the fire in now under control. However it will have set back production at a time when rivals are ramping up.

Docusign -4% pre-market despite reporting forecast beating Q4 results and an upbeat guidance. The stock has surged 200% across the past 12 months.

Where next for Docusign share price?

Despite surging 200% over the past 12 months, the rally started to lose momentum from October. The share price traded within an ascending channel which it broke out from in early March.
The stock sold off sharply as part of the broader tech rout before finding a floor at 185p.
The stocks trades below its 50 & 20 sma – a negative bias. Support can be seen at 200 round number ahead of 187.00.
Any attempt to further the recovery would need to break through 240 for more buyers to jump in.



Vaccine developments: AstraZeneca & Novavax

AstraZeneca’s share price is holding up considerably well considering that the number of countries that. The stocks trades -0.5% as more and more countries in Europe halts the use of the vaccine amid fears that it is linked to blood clotting.

Novavax +16% pre-market has reported that its covid vaccine is 96% effective in late trials against the original covid strain. It was also 86% effective against the British strain. The stock rallied over 8% in the previous session & trades firmly higher pre-market.


FX – UK GDP -2.9% MoM

The US Dollar is rebounding from yesterday’s selloff, tracing US treasury yields higher. DXY trades +0.4% at 91.80.

GBP/USD trades lower after data revealed UK economy contracted -2.9% in January vs 1.2% growth in December. Exports to the EU also plunged 40% in the month following Brexit.

GBP/USD trades -0.6% at 1.3903

EUR/USD trades -0.35% at 1.1929


Oil ends the week on a calm note

After some big swings through the week, oil is heading into the weekend approximately flat.

Oil prices jumped 2.4% on Thursday, boosted by Joe Biden signing off on the $1.9 trillion stimulus package in US and his pledge to vaccinate all American adults by the start of May. Future oil demand expectations rose in line with expectations of a much quicker US recovery.

OPEC revealed in its monthly report a downward revision in oil demand in the first half of the year, making last week’s OPEC+ group’s decision less surprising. OPEC also upwardly revised its demand estimates for H2.

Baker Hughes rig count data is due later today.

US crude trades +0.02% at $65.94

Brent trades -0.1% at $69.25

Learn more about trading oil here.

The complete guide to trading oil markets


Looking ahead

14:00 Canadian Jobs Data

15:00 Michigan Consumer Confidence

18:00 Baker Hughes Rig Count

Fiona Cincotta looks at the price action and levels to watch in USD/CAD here


StoneX Financial Ltd (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. CFD and Forex Trading are leveraged products and your capital is at risk. They may not be suitable for everyone. Please ensure you fully understand the risks involved by reading our full risk warning.

City Index is a trading name of StoneX Financial Ltd. Head and Registered Office: 1st Floor, Moor House, 120 London Wall, London, EC2Y 5ET. StoneX Financial Ltd is a company registered in England and Wales, number: 05616586. Authorised and regulated by the Financial Conduct Authority. FCA Register Number: 446717.

City Index is a trademark of StoneX Financial Ltd.

The information on this website is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement.

© City Index 2024